GovBidAlerts
← All opportunities
This notice has been superseded. See the latest notice: Olopatadine HCL 0.1% Ophthalmic Solution (Award Notice)

Olopatadine HCL 0.1% Ophthalmic Solution

All open bids & awards from Department of Defense →

Key dates

Posted
Aug 24, 2023
Response deadline
—
Archive date
Feb 15, 2028
Archive type
autocustom

Classification

Notice type
Award Notice
Base type
Award Notice
Set-aside
—
Set-aside code
—
PSC
6505

NAICS

Issuing office

Department
DEPT OF DEFENSE
Sub-tier
DEFENSE LOGISTICS AGENCY
Office
DLA TROOP SUPPORT
Office code
—
Organization type
OFFICE
Office address
PHILADELPHIA, PA, 19111, USA

Place of performance

Street
—
Street 2
—
City
Ontario
State
Canada
Zip
—
Country
CAN

Contacts

Description

Modification SPE2D223D0007 P00003 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Modification SPE2D223D0007 P00002 to incorporate clause FAR 52.204-27 Prohibition on a ByteDance Covered Application (JUN 2023) into subject contract. Modification P00001 SPE2D2-23-D-0007 revising the the price effective date and ship date from April 16, 2023 to February 28, 2023. Contract Award for Olopatadine HCL 0.1% Opthtalmic Solution 5ML Bottle

Award

Number
SPE2D223D0007
Amount
$17,621,453.20
Date
Feb 15, 2023
Awardee
GOLDEN STATE MEDICAL SUPPLY INC Camarillo CA 93012 USA
UEI
—
Awardee address
—

Other notices in this solicitation

Similar open contracts

Metadata

Notice ID
7f7f49c42aee40d0b4353023bc02fc01
Full path
DEPT OF DEFENSE.DEFENSE LOGISTICS AGENCY.DLA TROOP SUPPORT
Office code
—
Ingested
May 2, 2026
Updated
Jul 28, 2026